Monday 5 March 2018

DIABETIC COMPLICATIONS 2018

About Conference


Being recognized as a world-renowned organization, Conference Series Ltd takes pride to introduce the commencement of “International Conference on Diabetes and its Complications” from May 28-29, 2018 at Osaka, Japan. The Annual conference aims to provide an opportunity to share knowledge, expertise along with unparalleled networking opportunities between a large number of medical and industrial professionals in this sphere. The Annual Meetings gather renowned scientists, physicians, clinicians, surgeons, young researchers, industrial delegates and talented student communities in the field of diabetic medicine under a single roof where networking and global partnering happens for the acceleration of future research.

Conference Series Ltd through its Open Access Initiative is committed to making genuine and reliable contributions to the scientific community. OMICS Conference Series Ltd Publishing Group hosts over 700 leading-edge peers reviewed Open Access journals and has organized over 1000 scientific conferences all over the world.

Conference series Ltd welcomes all the scientists, physicians, clinicians, surgeons, young researchers, industrial delegates and talented student communities in the field of diabetic medicine to attend this Diabetes Conferences, where all the aspects of diabetes will be discussed under the single roof. Diabetes Asia Pacific-2018 will be an excellent amalgamation of academia and industry as it involves every aspect of empirical and conceptual thinking in exploring new dimensions in this field.  It is open to all types of research methodologies both from academia and industry.

Diabetic Complications 2018 is an international platform for presenting research about diabetes management and therapeutics, exchanging ideas about it and thus contributes to the dissemination of knowledge in the management of the disease for the benefit of the society. Diabetic Complications 2018 is where the future of management and novel therapeutics for the disease intersects.

Diabetes has increasingly become a lifestyle-related disease as it afflicts young and old. In 2016, the value of the diabetes therapeutics market in Asia-Pacific (APAC) countries was an estimated $7.5 billion, and it is forecast to grow at a Compound Annual Growth Rate (CAGR) of 7.1% between 2013 and 2020 to $10.5 billion. The latest report states that of the four major APAC countries (China, India, Japan and Australia), China will see the fastest expansion, with a CAGR of 11.1% over the forecast period. This will be driven by an increase in the prevalent population due to urbanization, advancement in the lifestyle of the people and by expected drug launches.

Conference Highlights

Posted by at No comments:
Subscribe to: Posts (Atom)